Literature DB >> 27313232

IgA1 Glycosylation Is Heritable in Healthy Twins.

Hannah J Lomax-Browne1, Alessia Visconti2, Charles D Pusey3, H Terence Cook1, Tim D Spector2, Matthew C Pickering1, Mario Falchi4.   

Abstract

IgA nephropathy (IgAN) is the most common form of primary GN and an important cause of kidney failure. Characteristically, patients with IgAN have increased serum levels of undergalactosylated IgA1 (gd-IgA1). To assess the degree to which serum gd-IgA1 levels are genetically determined in healthy individuals, we determined serum IgA and gd-IgA1 levels by ELISA in a sample of 148 healthy female twins, including 27 monozygotic and 47 dizygotic pairs. Using the classic twin model, we found the heritability of serum gd-IgA1 and IgA levels to be 80% (95% confidence interval, 66% to 89%) and 46% (95% confidence interval, 15% to 69%), respectively. These data indicate that serum gd-IgA1 levels are highly heritable. Elucidating the genetic basis of this heritability will be important in understanding the pathogenesis of IgAN.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  IgA nephropathy; gd-IgA1; glycosylation; human genetics

Mesh:

Substances:

Year:  2016        PMID: 27313232      PMCID: PMC5198287          DOI: 10.1681/ASN.2016020184

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  34 in total

1.  Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.

Authors:  Ali G Gharavi; Zina Moldoveanu; Robert J Wyatt; Catherine V Barker; Susan Y Woodford; Richard P Lifton; Jiri Mestecky; Jan Novak; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

Review 2.  IgA nephropathy.

Authors:  Robert J Wyatt; Bruce A Julian
Journal:  N Engl J Med       Date:  2013-06-20       Impact factor: 91.245

Review 3.  Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies.

Authors:  Krzysztof Kiryluk; Jan Novak; Ali G Gharavi
Journal:  Annu Rev Med       Date:  2012-10-16       Impact factor: 13.739

Review 4.  A retrospective analysis of the natural history of primary IgA nephropathy worldwide.

Authors:  F P Schena
Journal:  Am J Med       Date:  1990-08       Impact factor: 4.965

5.  Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.

Authors:  M Colleen Hastings; Zina Moldoveanu; Bruce A Julian; Jan Novak; John T Sanders; Kim R McGlothan; Ali G Gharavi; Robert J Wyatt
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-15       Impact factor: 8.237

6.  Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.

Authors:  Sachiko Shimozato; Yoshiyuki Hiki; Hiroko Odani; Kazuo Takahashi; Kouichiro Yamamoto; Satoshi Sugiyama
Journal:  Nephrol Dial Transplant       Date:  2008-01-04       Impact factor: 5.992

7.  O-glycosylation of serum IgD in IgA nephropathy.

Authors:  Alice C Smith; Jacob F de Wolff; Karen Molyneux; John Feehally; Jonathan Barratt
Journal:  J Am Soc Nephrol       Date:  2006-03-01       Impact factor: 10.121

8.  Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women.

Authors:  T Andrew; D J Hart; H Snieder; M de Lange; T D Spector; A J MacGregor
Journal:  Twin Res       Date:  2001-12

9.  Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.

Authors:  Krzysztof Kiryluk; Yifu Li; Simone Sanna-Cherchi; Mersedeh Rohanizadegan; Hitoshi Suzuki; Frank Eitner; Holly J Snyder; Murim Choi; Ping Hou; Francesco Scolari; Claudia Izzi; Maddalena Gigante; Loreto Gesualdo; Silvana Savoldi; Antonio Amoroso; Daniele Cusi; Pasquale Zamboli; Bruce A Julian; Jan Novak; Robert J Wyatt; Krzysztof Mucha; Markus Perola; Kati Kristiansson; Alexander Viktorin; Patrik K Magnusson; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Kari Stefansson; Anne Boland; Marie Metzger; Lise Thibaudin; Christoph Wanner; Kitty J Jager; Shin Goto; Dita Maixnerova; Hussein H Karnib; Judit Nagy; Ulf Panzer; Jingyuan Xie; Nan Chen; Vladimir Tesar; Ichiei Narita; Francois Berthoux; Jürgen Floege; Benedicte Stengel; Hong Zhang; Richard P Lifton; Ali G Gharavi
Journal:  PLoS Genet       Date:  2012-06-21       Impact factor: 5.917

Review 10.  New developments in the genetics, pathogenesis, and therapy of IgA nephropathy.

Authors:  Riccardo Magistroni; Vivette D D'Agati; Gerald B Appel; Krzysztof Kiryluk
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

View more
  14 in total

1.  A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.

Authors:  Richard A Lafayette; Pietro A Canetta; Brad H Rovin; Gerald B Appel; Jan Novak; Karl A Nath; Sanjeev Sethi; James A Tumlin; Kshama Mehta; Marie Hogan; Stephen Erickson; Bruce A Julian; Nelson Leung; Felicity T Enders; Rhubell Brown; Barbora Knoppova; Stacy Hall; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 10.121

2.  Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1.

Authors:  Daniel P Gale; Karen Molyneux; David Wimbury; Patricia Higgins; Adam P Levine; Ben Caplin; Anna Ferlin; Peiran Yin; Christopher P Nelson; Horia Stanescu; Nilesh J Samani; Robert Kleta; Xueqing Yu; Jonathan Barratt
Journal:  J Am Soc Nephrol       Date:  2017-02-16       Impact factor: 10.121

3.  Interaction between G ALNT12 and C1GALT1 Associates with Galactose-Deficient IgA1 and IgA Nephropathy.

Authors:  Yan-Na Wang; Xu-Jie Zhou; Pei Chen; Gui-Zhen Yu; Xue Zhang; Ping Hou; Li-Jun Liu; Su-Fang Shi; Ji-Cheng Lv; Hong Zhang
Journal:  J Am Soc Nephrol       Date:  2021-02-16       Impact factor: 10.121

4.  Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese.

Authors:  Xu-Jie Zhou; Lam C Tsoi; Yong Hu; Matthew T Patrick; Kevin He; Celine C Berthier; Yanming Li; Yan-Na Wang; Yuan-Yuan Qi; Yue-Miao Zhang; Ting Gan; Yang Li; Ping Hou; Li-Jun Liu; Su-Fang Shi; Ji-Cheng Lv; Hu-Ji Xu; Hong Zhang
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-18       Impact factor: 8.237

5.  GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway.

Authors:  Krzysztof Kiryluk; Yifu Li; Zina Moldoveanu; Hitoshi Suzuki; Colin Reily; Ping Hou; Jingyuan Xie; Nikol Mladkova; Sindhuri Prakash; Clara Fischman; Samantha Shapiro; Robert A LeDesma; Drew Bradbury; Iuliana Ionita-Laza; Frank Eitner; Thomas Rauen; Nicolas Maillard; Francois Berthoux; Jürgen Floege; Nan Chen; Hong Zhang; Francesco Scolari; Robert J Wyatt; Bruce A Julian; Ali G Gharavi; Jan Novak
Journal:  PLoS Genet       Date:  2017-02-10       Impact factor: 5.917

6.  Genetic variants of MCP-1 and CCR2 genes and IgA nephropathy risk.

Authors:  Jie Gao; Xinghan Liu; Linting Wei; Dan Niu; Jiali Wei; Li Wang; Heng Ge; Meng Wang; Qiaoling Yu; Tianbo Jin; Tian Tian; Zhijun Dai; Rongguo Fu
Journal:  Oncotarget       Date:  2016-11-22

Review 7.  New insights into the pathogenesis of IgA nephropathy.

Authors:  See Cheng Yeo; Chee Kay Cheung; Jonathan Barratt
Journal:  Pediatr Nephrol       Date:  2017-06-17       Impact factor: 3.714

Review 8.  C1GALT1 in health and disease.

Authors:  Xiaojie Sun; Mengru Zhan; Xun Sun; Wanqi Liu; Xiangwei Meng
Journal:  Oncol Lett       Date:  2021-06-06       Impact factor: 2.967

9.  O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.

Authors:  Viktoria Dotz; Alessia Visconti; Hannah J Lomax-Browne; Florent Clerc; Agnes L Hipgrave Ederveen; Nicholas R Medjeral-Thomas; H Terence Cook; Matthew C Pickering; Manfred Wuhrer; Mario Falchi
Journal:  J Am Soc Nephrol       Date:  2021-06-14       Impact factor: 14.978

10.  Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.

Authors:  Nicholas R Medjeral-Thomas; Hannah J Lomax-Browne; Hannah Beckwith; Michelle Willicombe; Adam G McLean; Paul Brookes; Charles D Pusey; Mario Falchi; H Terence Cook; Matthew C Pickering
Journal:  Kidney Int       Date:  2017-06-30       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.